- Conditions
- Paravertebral Catheter Insertion, Mastectomy, Breast Cancer
- Interventions
- Placebo (normal saline) Continuous Infusion, Ropivicaine 0.4% Continuous Infusion
- Procedure
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 1
- States / cities
- La Jolla, California
Source: ClinicalTrials.gov public record
Updated Apr 10, 2016 · Synced May 22, 2026, 3:00 AM EDT